BlackRock
DWTX

BlackRock’s Dogwood Therapeutics DWTX Stock Holding History

BlackRock’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46K Buy
28,546
+28,516
+95,053% +$47.2K ﹤0.01% 5199
2026
Q1 		$63 Hold
30
– – ﹤0.01% 5627
2025
Q4 		$125 Hold
30
– – ﹤0.01% 5471
2025
Q3 		$231 Hold
30
– – ﹤0.01% 5387
2025
Q2 		$143 Hold
30
– – ﹤0.01% 5406
2025
Q1 		$150 Hold
30
– – ﹤0.01% 5374
2024
Q4 		$75 Hold
30
– – ﹤0.01% 5356
2024
Q3 		$128 Hold
30
– – ﹤0.01% 5180
2024
Q2 		$162 Hold
30
– – ﹤0.01% 5238
2024
Q1 		$362 Hold
30
– – ﹤0.01% 5228
2023
Q4 		$434 Hold
30
– – ﹤0.01% 5292
2023
Q3 		$698 Hold
30
– – ﹤0.01% 5343
2023
Q2 		$1.04K Sell
30
-1,594
-98% -$45.5K ﹤0.01% 5405
2023
Q1 		$14.9K Buy
1,624
+54
+3% +$429 ﹤0.01% 5284
2022
Q4 		$9.26K Buy
1,570
+36
+2% +$271 ﹤0.01% 5468
2022
Q3 		$15K Buy
1,534
+926
+152% +$130K ﹤0.01% 5555
2022
Q2 		$65K Sell
608
-103
-14% -$10.8K ﹤0.01% 5360
2022
Q1 		$80K Sell
711
-35
-5% -$5.09K ﹤0.01% 5332
2021
Q4 		$95K Buy
746
+112
+18% +$14.2K ﹤0.01% 5286
2021
Q3 		$84K Buy
634
+248
+64% +$34.3K ﹤0.01% 5180
2021
Q2 		$61K Buy
386
+357
+1,231% +$50.6K ﹤0.01% 5156
2021
Q1 		$4K Buy
+29
New +$5.05K ﹤0.01% 5164

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock's DWTX Position: Q2 2026 in Review

BlackRock increased its Dogwood Therapeutics (DWTX) stake by 95,053% in Q2 2026, buying an estimated $47.2K and bringing the position to 28,546 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #5199.

BlackRock first reported a position in DWTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $95K in Q4 2021. 15 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • BlackRock held 28,546 shares of Dogwood Therapeutics worth $46K as of Q2 2026.
  • BlackRock bought 28,516 Dogwood Therapeutics shares in Q2 2026, an estimated $47.2K.
  • Dogwood Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5199 holding.
  • BlackRock first reported a position in Dogwood Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • BlackRock's Dogwood Therapeutics position peaked at $95K in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.